Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein

BACKGROUND: Hepatitis C virus (HCV) genotype 3a is known to show comparatively better response to combination therapy than genotype 1 and 4. Mutations within NS5A gene of HCV have earlier been implicated with response to interferon (IFN) therapies in chronic HCV patients among various populations. A...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ali, Ijaz, Khan, Sanaullah, Attaullah, Sobia, Khan, Shahid Niaz, Khan, Jabbar, Siraj, Sami, Iqbal, Aqib, Swati, Zahoor A, Idrees, Muhammad
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2011
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3118205/
https://ncbi.nlm.nih.gov/pubmed/21609495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-8-258
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires